Vijaya Diagnostic Centre Ltd

AI
Vijaya Diagnost. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Vijaya Diagnostic Centre Ltd

₹ 1,559 3.51%
18 Sep - close price
vijayadiagnostic.com BSE: 543350 NSE: VIJAYA
About

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]

Key Points

Market Leadership:[1][2]
The company is the largest integrated B2C focused diagnostic chain in India with 162
state-of-the-art centres spread across 27
cities & towns. It was among the first of independent diagnostic centres in South
India to offer PET CT from Wipro GE Healthcare in 2008.

Website BSE NSE
  • Market Cap ₹ 16,056 Cr.
  • Current Price ₹ 1,559
  • High / Low ₹ 1,578 / 848
  • Stock P/E 83.2
  • Book Value ₹ 91.7
  • Dividend Yield 0.13 %
  • ROCE 21.5 %
  • ROE 19.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 17.0 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of Nifty MidSmallcap 400 BSE Healthcare Nifty 500 Nifty Smallcap250 Momentum Quality 100 Nifty500 Equal Weight

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
119 136 129 141 142 170 156 162 177 189 193 207 219
71 80 78 84 87 100 94 97 107 111 110 115 124
Operating Profit 47 56 51 57 56 71 62 65 71 79 83 92 95
OPM % 40% 41% 40% 41% 39% 41% 40% 40% 40% 41% 43% 44% 43%
6 7 3 3 4 5 5 4 7 5 6 7 9
Interest 6 6 6 6 6 6 6 7 7 7 8 9 10
Depreciation 12 14 14 15 15 15 17 17 18 19 21 21 22
Profit before tax 35 44 34 40 38 54 44 46 53 57 59 69 71
Tax % 26% 25% 25% 23% 25% 26% 24% 27% 26% 25% 25% 23% 25%
26 33 25 31 29 40 34 33 39 43 44 53 53
EPS in Rs 2.55 3.21 2.47 2.98 2.81 3.87 3.27 3.26 3.80 4.16 4.30 5.14 5.17
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
238 279 329 367 451 450 525 634 765 808
160 187 196 204 251 271 313 379 443 460
Operating Profit 78 92 133 163 200 179 212 255 322 347
OPM % 33% 33% 40% 44% 44% 40% 40% 40% 42% 43%
5 9 12 11 13 15 19 17 25 27
Interest 4 4 15 15 16 21 24 25 31 34
Depreciation 23 26 48 50 52 61 55 65 80 84
Profit before tax 56 70 82 110 144 111 152 183 236 256
Tax % 36% 31% 25% 24% 25% 25% 25% 26% 25%
35 49 61 83 108 83 115 136 178 193
EPS in Rs 78.17 108.02 135.13 18.28 10.60 8.15 11.20 13.24 17.33 18.77
Dividend Payout % 0% 0% 0% 0% 9% 12% 9% 15% 12%
Compounded Sales Growth
10 Years: %
5 Years: 16%
3 Years: 19%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: 15%
3 Years: 27%
TTM: 32%
Stock Price CAGR
10 Years: %
5 Years: 22%
3 Years: 51%
1 Year: 47%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 18%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5 5 5 5 10 10 10 10 10
Reserves 162 211 273 356 460 535 643 770 933
26 36 156 137 183 248 250 292 396
31 40 41 36 58 57 59 149 120
Total Liabilities 224 292 475 533 711 850 962 1,221 1,460
102 137 264 261 364 517 582 673 862
CWIP 3 3 10 9 34 28 9 67 35
Investments 77 73 58 32 59 144 254 326 368
42 80 143 231 254 161 117 154 195
Total Assets 224 292 475 533 711 850 962 1,221 1,460

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
62 77 109 128 155 163 175 208 256
-100 -91 -34 -129 -127 -108 -139 -167 -166
-7 8 -28 -48 -25 -41 -43 -47 -63
Net Cash Flow -44 -7 46 -49 4 13 -8 -5 27
Free Cash Flow 31 18 62 97 35 38 92 137 91
CFO/OP 105% 104% 99% 97% 97% 105% 98% 96% 95%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 14 14 9 7 8 7 9 7 10
Inventory Days 24 19 23 16 22 12 26 18 18
Days Payable 152 175 163 133 108 172 178 141 143
Cash Conversion Cycle -115 -142 -130 -110 -79 -153 -143 -116 -114
Working Capital Days -22 -28 -40 -21 -32 -37 -28 -47 -35
ROCE % 33% 27% 27% 28% 18% 19% 20% 22%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
B2C Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Diagnostic Centres
Nos
Footfalls
Mn
Tests per Footfall
Nos
Tests Performed
Mn
Radiology Revenue Mix
%
Wellness Revenue Share
%
Hyderabad Revenue Contribution
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.90% 54.87% 54.06% 53.92% 53.91% 53.91% 53.05% 52.63% 52.60% 52.60% 52.51% 52.51%
20.68% 19.95% 20.09% 20.08% 18.14% 17.54% 19.36% 19.56% 18.27% 15.10% 13.38% 11.65%
18.64% 19.82% 20.80% 21.49% 23.45% 24.62% 23.72% 24.07% 25.34% 28.60% 29.93% 31.61%
5.78% 5.36% 5.03% 4.50% 4.49% 3.92% 3.86% 3.73% 3.77% 3.70% 4.17% 4.22%
No. of Shareholders 72,79566,20466,72462,41562,25860,95266,89162,11558,99457,78462,94667,251

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls